No Impact of Corticosteroid Use During the Acute Phase on Persistent Symptoms Post-COVID-19
Open Access
- 18 August 2022
- journal article
- research article
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 15, 6645-6651
Abstract
Persistent COVID-19 symptoms may be related to residual inflammation, but no preventive treatment has been evaluated. This study aimed to analyze, in a prospective cohort, whether corticosteroid use in the acute phase of COVID-19 in hospitalized patients may reduce the risk of persistent COVID-19 symptoms. A total of 306 discharged patients, including 112 (36.6%) from the ICU, completed a structured face-to-face assessment 4 months after admission. Of these, 193 patients (63.1%) had at least one persistent symptom, mostly dyspnea (38.9%) and asthenia (37.6%). One-hundred and four patients have received corticosteroids. In multivariable adjusted regression analysis, corticosteroid use was not associated with the presence of at least one symptom (OR=1.00, 95% CI: 0.58– 1.71, p=0.99) or with the number of persistent symptoms (p=0.74). Corticosteroid use remained ineffective when analyzing the ICU subpopulation separately. Our study suggests that corticosteroid use had no impact on persistent symptoms after COVID-19 in discharged patients.Keywords
This publication has 20 references indexed in Scilit:
- Persistent Post–COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid TreatmentAnnals of the American Thoracic Society, 2021
- Corticosteroids in patients hospitalized for COVID-19 pneumonia who require oxygen: observational comparative study using routine care dataClinical Microbiology and Infection, 2021
- ‘The long tail of Covid-19’ - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patientsF1000Research, 2021
- Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital dischargeeClinicalMedicine, 2021
- ‘The long tail of Covid-19’ - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patientsF1000Research, 2020
- ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19Thorax, 2020
- Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infectionPLOS ONE, 2020
- Assessment and characterisation of post‐COVID‐19 manifestationsInternational Journal Of Clinical Practice, 2020
- Persistent Symptoms in Patients After Acute COVID-19JAMA, 2020
- The Pathology of Severe COVID-19-Related Lung DamageDeutsches Ärzteblatt international, 2020